Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

Duvelisib and other PI3K inhibitors in CLL

Editor By No Comments1 Min Read

Susan M. O’Brien, MD of University of California Irvine discusses Duvelisib and other PI3K inhibitors in CLL at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

Share.

Related Posts